0000000000017877

AUTHOR

C. Linea

showing 6 related works from this author

Delayed-Onset Superior Mesenteric Artery Syndrome Presenting as Oesophageal Peptic Stricture

2012

Superior mesenteric artery (SMA) syndrome is an infrequent cause of vomiting and weight loss due to compression of the third part of the duodenum by the SMA. We describe the case of a 17-year-old woman, admitted to our department for progressive dysphagia and severe weight loss due to an oesophageal peptic stricture, caused by chronic acid reflux secondary to duodenal compression by the SMA. Symptoms improved after (par)enteral nutrition and repeated oesophageal dilatation, thus supporting the role of intensive medical and endoscopic intervention as an alternative to surgery, at least in some cases.

medicine.medical_specialtySettore MED/09 - Medicina InternaPepticGastroenterologymedicine.arteryInternal medicinemedicineOesophageal dilatationSuperior mesenteric arterySuperior mesenteric artery syndromelcsh:RC799-869Settore MED/12 - Gastroenterologiabusiness.industryGastroenterologymedicine.diseaseSMA*DysphagiaParenteral nutritionmedicine.anatomical_structureVomitingDuodenumlcsh:Diseases of the digestive system. Gastroenterologymedicine.symptomPublished online: March 2012businessSuperior mesenteric artery syndromeChronic acid refluxCase Reports in Gastroenterology
researchProduct

Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study

2006

1. Aliment Pharmacol Ther. 2006 Mar 15;23(6):721-6. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Andriani A, Zullo A, Di Raimondo F, Patti C, Tedeschi L, Recine U, Caruso L, Bonanno G, Chiarenza A, Lizzani G, Miedico A, Romanelli A, Costa A, Linea C, Marrone C, Mirto S, Mistretta A, Montalbano L, Restivo G, Vinci M, Bibas M, Hassan C, Stella F, Cottone M, Morini S. Department of Haematology and Gastroenterology, 'San Giacomo' and 'Nuovo Regina Margherita' Hospitals, Rome, Italy. BACKGROUND: Although the stomach is the most frequent site of intestinal lymphomas, few data are available on both clinical endoscopic presentation of gastric lymphoma and p…

Malegastric lymphoma.helicobactermedicine.medical_specialtyLymphomaSettore MED/12 - GASTROENTEROLOGIAGastroenterologyEndoscopy GastrointestinalHelicobacter Infectionsimmune system diseasesStomach Neoplasmshemic and lymphatic diseasesInternal medicinemedicineGastric mucosaHumansPharmacology (medical)AntrumNeoplasm StagingRetrospective StudiesHepatologymedicine.diagnostic_testbiologyHelicobacter pyloribusiness.industryGastric lymphomaStomachStomachGastroenterologyRetrospective cohort studyHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationEndoscopyLymphomamedicine.anatomical_structureGastric MucosaFemalebusiness
researchProduct

An Unusual Presentation of Zollinger-Ellison Syndrome

2013

Abstract Zollinger-Ellison syndrome is an often progressive, persistent and frequently life-threatening disease, described for the first time as characterized by ulceration of the upper jejunum, hypersecretion of gastric acid and non-beta islet cell tumors of the pancreas; this syndrome is due to the hypersecretion of gastrin. We report a case of Zollinger-Ellison syndrome presenting as severe esophagitis evolving in stenosis, which demonstrates how a delayed diagnosis may induce risk of disease spreading. In this setting new diagnostic approaches, such as somatostatin receptor scanning and positron emission tomography with 68 Ga-labeled octreotide, could be particularly useful, as well as …

Positron emission tomographyPathologymedicine.medical_specialtySettore MED/09 - Medicina InternaOctreotideZollinger-Ellison syndromePublished online: January 2013medicinelcsh:RC799-869GastrinSomatostatin receptorbusiness.industryGastroenterologyZollinger ellison. severe esophagitismedicine.diseaseZollinger-Ellison syndromemedicine.anatomical_structureOctreoscanRadionuclide therapyGastric acidlcsh:Diseases of the digestive system. GastroenterologyEsophageal stricturesPancreasbusinessEsophagitismedicine.drugCase Reports in Gastroenterology
researchProduct

Efficacy of pneumatic dilatation for the treatment of idiopatic achalasia: a single-center experience

2015

Pneumatic dilatation (PD) and Surgical Miotomy (SM) are presently the best treatments for untreated achalasia, with similar efficacy. There is no information on the relative efficacy of PD in younger compared to older patients. Aim of our study was to compare success rate and safety of PD in patients under fifty years old and in those over fifty years old affected by achalasia. Twenty consecutive symptomatic patients were treated in our Unit with graded PD under fluoroscopic view. Five male and 15 female with a median age of 47 years were treated. Twelve patients were less than fifty years old (group I) while 8 were older (group II). Median dysphagia questionnaire score was 14 and13 ingroup…

MarketingPharmacologySettore MED/12 - GastroenterologiaOrganizational Behavior and Human Resource Managementmedicine.medical_specialtyRelative efficacybusiness.industryStrategy and ManagementGroup iiComplete remissionPharmaceutical ScienceAchalasiamedicine.diseaseSingle CenterDysphagiaSurgerySettore MED/18 - Chirurgia Generaleachalasia pneumatic dilatation esophageal obstructionOlder patientsDrug DiscoverymedicineIn patientmedicine.symptombusinessAbdomen
researchProduct

Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study

2009

Abstract Background/Aim Data on management and long-term follow-up of Helicobacter pylori -associated MALT-lymphoma in clinical practice are scanty. We evaluate the long-term efficacy of H. pylori eradication on low-grade MALT-lymphoma, and the efficacy of further therapies in refractory patients. Methods This study enrolled patients with stages I–II 1 MALT-lymphoma and H. pylori infection. H. pylori eradication was attempted in all patients. Patients with lymphoma persistence or progression following H. pylori treatments received further lymphoma treatments. Both 5-year and disease-free survivals were calculated. Results Sixty patients (stage I/II 1 : 50/10) were followed up for a median t…

AdultMaleVincristinemedicine.medical_specialtyCyclophosphamideSettore MED/12 - GASTROENTEROLOGIAGastric maltomamanagementKaplan-Meier EstimateGastroenterologyDisease-Free SurvivalHelicobacter InfectionsYoung AdultStomach Neoplasmsimmune system diseasesPrednisonehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansYoung adultCyclophosphamideAgedRetrospective StudiesAged 80 and overHelicobacter pyloriHepatologybiologybusiness.industryGastroenterologyProton Pump InhibitorsMALT lymphomaRetrospective cohort studyLymphoma B-Cell Marginal ZoneMiddle AgedHelicobacter pyloribiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsLymphomaSurgeryItalyDoxorubicinVincristinePrednisoneFemalebusinessFollow-Up Studiesmedicine.drug
researchProduct

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.

1997

Several randomized clinical trials of interferon in chronic hepatitis C have examined the histological changes in paired biopsy specimens. We have attempted a quantitative evaluation by meta-analysis.Randomized Clinical Trials found by MEDLINE search were included if: a) they compared different IFN regimens with non-active treatment or with each other, b) they obtained biopsies before starting and at the time of stopping IFN in a sizable proportion of the treated and control patients, and c) they assessed the biopsy-specimens semi-quantitatively according to Scheuer's numerical scoring system or Knodell's Histological Activity Index, with quantitation of fibrosis and of lobular, portal and …

Adultmedicine.medical_specialtyPathologyBiopsyMEDLINEGastroenterologylaw.inventionRandomized controlled trialLiver Function TestslawInterferonFibrosisInternal medicineBiopsyMedicineHumansRandomized Controlled Trials as TopicHepatologymedicine.diagnostic_testbusiness.industryHistologyAlanine Transaminasemedicine.diseaseHepatitis CLiverMeta-analysisHistopathologyInterferonsbusinessLiver function testsmedicine.drugJournal of hepatology
researchProduct